Investor Overview

Our Investor Information

Company Overview

Rhythm Pharmaceuticals is a commercial-stage biopharmaceutical company committed to transforming the care for patients living with rare genetic diseases of obesity.

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Annual Report
Press Releases
November 13, 2023
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
November 7, 2023
Rhythm Pharmaceuticals Reports Third Quarter 2023 Financial Results and Business Update
Upcoming Events
December 6, 2023 at 8:00 AM EST
Rhythm Update on MC4R Pathway Programs
Investor FAQs
More FAQs are coming soon.


Delaware, November 2008


222 Berkeley Street, 12th Floor
Boston, MA 02116

CUSIP number


Transfer Agent

Computershare Trust Company, Inc.
250 Royall Street
Canton, MA 02021
US Phone: +1-800-962-4284
International Phone: + 1-781-575-3120